Tandem Diabetes Care (TNDM) 22 Feb 232022 Q4 Earnings call transcript

Good day, and welcome to the Tandem Diabetes Care Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

It is now my pleasure to introduce Executive Vice President and Chief Administrative Officer, Susan Morrison. Morrison? Susan

and future you Today's XXXX statements. discussion could statements. reflect performance expectations that or Thank of today's and actual year-end quarter projected These those anticipated results joining time management's call. development earnings will about to for everyone. in only date. and financial speak fourth as Tandem's and statements lines Hello, forward-looking are and There operating risks product from our events, plans include cause uncertainties differ forward-looking materially

report other of factors materially and forward-looking today publicly press list any in events XX-K information, annual or that and whether A our or on forward-looking Form results could SEC earlier these to different implied new factors. We under to cause the be obligation statements of elsewhere expressed a in issued our actual is in Risk update no highlighted any from as future Factors those other assume statements, release and most by of filings. our result recent portion

addition, indicative performance ongoing reporting to operations. information of of we financial We is these periods. across and non-GAAP measures our core our measures a Non-GAAP our to that references today's financial discussion GAAP measures. investors are results financial non-GAAP facilitate believe number and provided In reflects operating operating of includes give comparisons believe business better

release our about information earlier press to additional our For issued refer financial use non-GAAP please today. of measures,

President Executive CEO; President Officer. Vice call Financial led Today's Sheridan, Leigh and and will be our Vosseller, John and by Chief our

back the advance for for call up queue. question in prepared limiting before you remarks, one their Following open Thank the we'll yourself into to getting questions.

call John. now turn over to I'll the

with you with continue In XX employees with our efforts, with This, technology to that our the more expand than Thank diabetes. our we to worldwide having customers customers and today's our insulin overwhelmingly people to and continued management. levels installed t:slim passion high XXX,XXX are allow therapy for insulin demonstrates the therapy transform XXXX, Susan, in to advancing Thanks, talented using now improve to combination us base to their new to needs. of everyone Tandem mission welcome, report positive experience dedication record services and the its whose call. lives

Before diving first into take moment from to year. of results, acknowledge our a I some wanted the to achievements

iOS FDA received enables of we meaningful was the the mobile iOS users, a This the only smartphone. continue clearance that cleared be as insulin pump accomplishment First, system their delivering through t:slim to app or our bolus FDA insulin an XX Android from we device.

broad and Next The bolus outcomes populations, controlled is including is people year diabetes. us poorly feature, in immediate allows this clinical of technology. improvements strength substantially its outcomes the across completed range consistency Control-IQ automated with on Control-IQ's a positive and of deliver which and our to to best-in-class most sustained correction clinical studies linked presented diverse

Pump. set Both acquisitions: our set I'd laid to innovation different advancements vision Medical, many demonstrate offering the two a Patch we year the on ways. was meet of and These by Lastly, commitment executing just that highlight diabetes. recent developer Capillary AMF preferences even insulin unique wear that to over worldwide a with strategic illustrates the of needs of living technology ago a portfolio developer in in the like people solutions adoption year pumps of infusion study the of the Biomedical, our increase to Sigi out extended how are our we and

more challenging in commercial In line past. Turning we with to our both results. than recent demonstrated another growth even year top XXXX, of year-over-year environment a

users we as insulin who also worldwide are In Tandem's of technology current to benefit pumpers. the expanding well on focused as U.S., to a t:slim again. new existing the Tandem once efforts pump sales eligible pump the Our market focused purchase introducing on

progress of reflected quarter that throughout fact in target the our they for in XXXX, pump each each approximately U.S. in that therapy the were We which across new adopting is populations, pump. reported converted customers these quantify. time adoption the half pumpers and demonstrated half we from new first using and pumpers other is a the United different breakdown more the Outside although pumps, competitor existing difficult of manufacturer's both of States, also to the of

echoed meeting, commercial serve, Overall, with people offers. quarter very positive diabetes an great the the care it regard stories in immediate our adopting high such sentiments impact lives provider the our was technology strongest worldwide countries XX we the approximately enthusiastic t:slim it and XX% of in positive than of with year. QX be the technology exchanging excitement global our ahead. was benefits growth with team makes This in Health where at to people saw opportunities more on our the technology the for with sustained for the remains being of recent on Control-IQ we

success We was renewal focus of saw demonstrates people to increased satisfaction people XXXX who Our our the also the people renewal renewals. number with high the a technology. U.S. renew the actually purchasing with eligible but coupled steadily strong retention our renewed This, not of pumps, the of year. in-warranty Meeting experience in discussion. level in of throughout growth portion the strong of customers of eligible in very overall another only rate

people a XXXX year continued eligible to are in beyond, each meaningfully. growth of number Customer renew and catalyst for our scales renewals who as the are key company

penetrated the just months. in and United typically the we The States. the which to on outside serve market continuing over focus to pump have geographies look we dynamics be commercial XX% As to overall will and XX% XX% large in consistent U.S. only ahead, our the the market, expand insulin in remained year remains growing recent

completed cartridge capacity our to for manufacturer, transfer to the this for newest Control-IQ we recently best-in-class to launches. preparing new We the which our In production drive our while help in manufacturing scale creates XXXX, our operations. for ways t:slim preparation us focused product cartridge of Part are third-party Tandem creative awareness technology, pump, on Mobi. multiple of our of is lines

and to at opportunities while in continuing R&D and we our internal looking marketing diligent with automate processes. invest and spending Operationally, to streamline efforts remain

Our technology that recent it the leverage intensive is the while features effort can focus our to responsive is of of example good This update our mobile-first improving an support that capability development. in of is portal. as continuously burden operational infrastructure perspective experience. us faster from this infrastructure a customer the reduce headcount allows It for an scalable to create iterative costs. for better customer A back our enables important end

web-based Tandem planning we're second a this as application generation rollout we deploy that source, begin our summer. data toward management It's also a step meaningful to on global move scaled

data Source in success than management through is already t:slim the designed have our more key data application of the million to Connect which we U.S. the patient users years X.X build on from of

customization person. data added provides health to interface manage visualization clinical providers enhances and better care, Source or patient's for their care remote in whether

also to wear as planning addition portfolio to Tandem and for expand source, to operate In underway in well they will greater they pump our Mobi, launch efforts want want of we how choice their which have as solutions offer how people it. diabetes

launch people otherwise growth. is We a research today further the our shows of pump in that with for questions market adopt insulin segment the options not Mobi catalyst driving XXX(k) to would and start a As received we've the therapy discussed who largely to from We response a appeals past, available to and year. in we difficult are the responses. activities this preparing one following preparing timing predict, FDA of for launch to beginning aim are quarter remains our clearance. half in our and Clearance shelled second within

this year Excitingly, in which is to innovations commercialization. development we have slated from multiple to move a new

XX integration. the launch commercial availability are GX efforts the upcoming with Our focused on currently of t:slim

QX. clearance, our and are with plan worldwide and integration begin final availability recent is we later to Dexcom's completing Following updates scaling our current launch labeling activities in

with in users and is it with they Dexcom the cleared to the the be proud to commitment bring for latest XX sensors their an we've diabetes goal be as system, be GX generation integrated market the FDA. the our charge home. convenience by be are rolled on This update to of integration can by no with t:slim people done AID to the will existing integration of technologies are software and fourth delivering out customers to first in-warranty in be will Our

Libre launch Furthering once available with one receive integration our Libre expansion is work received, is Libre It's the bring goal this an FDA another to FreeStyle shared Abbott pump AID technology to commence and a our insulin living the in opportunity for commitment the more delivery to of with quarters. commercial technology. future system. an for using diabetes. clearance States in new offering catalyst with exciting automated the with is is And market to with two to insulin the It's to the also t:slim Abbott integrated people of that as XX not integrate working our within today. United benefits

In clinical these pipeline, also in XXXX. number underway opportunities addition to of we initiatives near-term a have our in

and For use. second X.X, feasibility ease is Control-IQ study which designed in example, for enhanced greater offer we've enrollment even begun a to personalization of

preparing to addition, support to a type In indication for X we're a Control-IQ. start pivotal study

initiative set that set, Capillary year Biomedical acquired the for is we year. technology, is the trial study clinical this infusion major extended last last wear Our with which

features indications filings studies, XXXX anticipate along work regulatory future update. R&D data We expand with new to products, people our from for these diabetes. and with benefits and living the Rounding lately our bring in Control-IQ underpin the will work as out

around execute to in not strategy, a that longer-term there fall management. on one-size centers continuing a portfolio fit our which solution is understanding insulin therapy are We fundamental

can living to of include choice allow is the a operate worn algorithms. tube of that means ultimate working like we to battery life and consumable varying deliver people preferences features, solutions processor factor device future and with form and family wireless users expand To extension and and that choice with a Mobi a a it body, pump. features choice and be serve sight that here infusion longer require faster choice. to This are flexibility. how choice We're providing needs and a version the the software working diabetes, will for tubeless to updates, t:slim also offerings of include a of on why or support their This we portfolio to set our next-generation wear in will

privately of month. the held acquired a Medical of insulin patch AID developer its Patch newest use burden element compatibility the pump diabetes is Swiss rechargeable AMF reduces which cartridge in an be its technology. through last ergonomic The portfolio Sigi with prefilled designed that we managing our a to Sigi is with pump, and

look AMF we team forward closed, on to closely commercialization working development, the product regulatory it's more that and with Now strategy. the

is every months. founded the to to technology innovation company new bring community a was it XX And diabetes on months to our and goal XX

front in of portfolio the us, well that With product on to of offerings our our strength will a today and execute growth longer-term series goals. near- to we drive of our catalysts us are new positioned and allow

call that, to I'll over With Leigh. turn the now

you, Thank John.

$XXX full efforts. sales year to up this we setting pump have of XX% XXXX records years. achievement, year. and expand exceeded Our competitive million sales throughout the more sales market, drive quarterly in Pumps our made With three than success share insulin in doubled our renewal we continue capture the as our

were basis on $XXX sales $XXX and worldwide. quarter shipments non-GAAP Fourth XX,XXX million GAAP on a pump million

for sales Choice to to a newest the GAAP of our access the pathway related provides customers reflect U.S., an in our which Our program recent deferral accounting pumps. introduction Tandem our

question of better aid the sales when to sale with or at how the note in is economics deferred It business. and reflect deferred when It's does the reimbursed sales of the to of of be are consistent is important not program pump risk. each non-GAAP t:slim for change and computed XX historical Our sell recognized. today none much a progress to order measuring revenue we merely this will periods we

sales by XXXX down our geography. Breaking

million a were $XXX GAAP a basis. non-GAAP on U.S. on Our sales million $XXX and basis

of XX% were growth drivers from largest more installed our which customers. the U.S. sales increase now One at base, XXX,XXX than in supply year-over-year a is

rates. renewal increasing numbers and volume also in our are both We

pumps increased fourth quarter warranties Related a XX% U.S. saw the already in And XX% these for shipments XXXX. the in expired year. customers XX,XXX XX%. we renewed renewal perspective, alone, have volume, in From in the in Overall, we a rate XXXX. to of increase shipments over we shipped whose

QX. basis a basis. in when reflecting million increase were an a $XXX shipped Fourth renewal to pumps, GAAP We quarter new on and pump $XXX both sales in the on U.S. non-GAAP XX,XXX shipments compared million and

well by XX% to XXXX as country XX% XXXX overall were Turning the the The sales growing customers increase our progress increases of as U.S. end installed our base price came year-over-year. majority growth million, supply outside of and XXX,XXX sales the benefit in with reaching mix. from $XXX from

pump largely by This challenges were of timing flat grew warehouses. to year-over-year. actual from and patterns difference Their orders their have Diego variation Customer San distributors. shipments and managing in-country ordering relates our the been logistics significantly while placements approximately implanted XX%, between

the transition distribution the demand customer center, expect began both and end supply creating of of of of across in completion third This to Upon European headwind transition pump alignment sales approximately we late in to quarter. fourth the our to closer see million sales with the quarter a $X impact orders. heaviest XXXX,

Our million resulting fourth quarter on shipments. sales were $XX pump XX,XXX

XXXX present a Looking $XXX from basis, the million million opportunities growth sales product anticipated our some scale of worldwide shift up slightly to accelerate indication of from launches center of to timing widening initial to does in providing to related the in on that multiple range rate XX% of distribution factor does ahead, a year not John Europe. we discussed, guidance XX%. to which are XXXX to sales our the include It our growth. This $XXX non-GAAP new

from stream supplies to The predictable leading environment U.S. which expected business, non-GAAP consistent and largely U.S. our sales grow. in XXXX. of year, products experienced reoccurring we to nearly with we operating a of to have in reflect we benefit pieces be renewals both for that expected This expectations months recent to the the the XX% of in does sales have remains $XXX make are what revenue the and $XXX U.S., not million in range potential in more million. as contemplates been our up are new

decline we create increasing the the in Keep past including when our demonstrated insurance and which opportunity consider have from to extent due that year. sales Renewals to an dynamics. fourth quarter you first overall that this years typically the U.S., mind in four in scaled the ago renewals business rates improvement the in the

shipments in $XXX million In to expected the the last $XXX patterns averaged are sales supply in has sales is the With follow first sequential the quarters. average and The years, year XX%. three the both of that remainder for across historical where U.S. quarter decline be to range in pump scale pump expected mind, to of seasonal the million. up

Sales been $XXX markets the transition expected $XX distribution the XXXX This largest related outside a total for to of to center. of The approximately be mid-year. to QX expected be in European in the new to million. million will U.S. our be has impact million are to heaviest headwinds range the in complete $XXX is of and

QX result, be in expected As a sales outside periods the a million of U.S. are to the million. range in $XX than historical as to $XX lower sales of percent

margin our in From to XX% XXXX. XXXX a perspective, gross margin XX% was compared

was prior supply Our attributed higher and primarily cost higher materials from pressures reductions XXXX. performance step and was raw mix that across from as to consistent we prices early in offset certain our year of down the higher benefited the point anticipated selling operational X average acquired sales. percentage year cost The from to

gross the GAAP non-GAAP of gross with and XX% higher of a The our expected to half approximately be XXXX. margin XXXX the the at expect non-GAAP difference Our on a basis in raw remaining Choice turn was we in results materials program. fourth first sales to margin to Tandem cost In inventory impact due our on is line XX%. the the XX% basis of XXXX, quarter

new follows extended in periods progress such as sales infusion product set meaningful The the Mobi future expected across is and generally margin come Gross our in U.S. leverage wear technology. sales to introductions, most improving with expectations. line year pump from

$XX as of our at well work of acquisition. these XXXX $X including our evaluate sales impact for of the for of unique and a certain negative million range in expectations. of quarter as or costs transactions excluding XXXX third stock-based the the program. in our of transactions, Biomedical EBITDA impact long-term facility Choice the charge environment, in quarter X% the hybrid Capillary a to compensation, When XX% line with we in noncash with adjusted fourth non-GAAP for non-recurring footprint as associated the was Tandem million margin continue operating the closing million reflected Our consolidation in $XX

move the by be into This X% initiatives. will R&D sales. EBITDA costs non-GAAP leverage SG&A adjusted R&D of XXXX, related to investment margin additional of of we in As investment our operating X% the recent of from acquisitions that be offset to sales. we productivity includes X% partially range in expect for This increased will our approximately in

against the EBITDA with SG&A scale be outside from as States adjusted is sales sales margin expected anticipate be the a half will margins Our EBITDA To headwinds across with year. in adjusted first in half our of second and builds clear, the the that expected return of current year negative efficiencies. to United to the benefit positive a the spending expectations margin line levels, we with in XXXX

to focused We diligently Turning generating cash. both inorganically. remain and cash to free provide to grow business, on organically the flexibility flow

and million is total the compared the sheet XXXX. at of investments the at end strong million end year balance with $XXX $XXX cash Our in of to

cash $XX million strategic providing stock and $XX million fund operating generated activities. flow We the $XX from opportunity million in employee to programs of

to tech is in manufacturing center, invested near improvements also largely completion. our $XX new which million scale-up and expenditures We capital for related leasehold

range sales of XXXX worldwide our million. are $XXX to including summarize sales To million the million million, outlook, of estimated to $XXX $XXX non-GAAP be to $XXX in OUS

sales. margin to be to is and the approximately adjusted of gross estimated X% X% expectation of is non-GAAP XX% in Our range EBITDA

Our are approximately with non-cash million, and with $XX to comp compensation, depreciation. associated is P&L $XXX expected of million $XX stock be which depreciation charges for amortization million stock and

John. to back call the turn now will I

Leigh. Thanks,

Kim our press issued over several Tandem been that instrumental be Board duties begin Kim Robertson. will has the handing the of CEO as his in I'd company then to member, Becky leader an the like since our of for we fellow Directors release today and separate serving announcing of Q&A, joining Chair Blickenstaff XXXX, Board we years. for Before acknowledge to chair first

strategic start-up build to a from His company helped and vision Tandem worldwide in focus and mission shape diabetes on has to culture our VC back leader driven care.

a global While individuals perspectives been number other our new in and and expertise serving connected diverse Board, as has skills care on on and bringing managed of our a for focus of and talented Kim with evolving health, a expansion. directors that technology, consumer Chair,

in early record tremendous added Tandem's Robertson an Board impressive roles She's and value and companies executive strategic with a board Beckie along with device experience our and in business models. of natural a range to member. her as scale engineer helping centric expanded joined leadership medical and XXXX of bringing track It's an patient choice entrepreneur, for the Board, technologies position. with vision, a corporate

Thank your continued of Becky, you Kim company. we and to appreciate contributions the again to and Board our

for And the with turn to questions. back operator I'll that, the over call

[Operator first Instructions] from Miksic you. And Barclays. Matt comes Thank line our with question the of

Matt. Hi,

much to to Thanks the you the conservatism puts for appreciate I around on and maybe X% sure just get making year. you questions getting that this Hi. of that so around sort But again, we direction. sort kind time. in walk we're of you're the of that I understand the X% that investments The top EBITDA you make to taking number through, the mentioned? coming margin line. could takes wanted us just

is line. I'll margin in makes We the projected we difference gross question, a you may pricing new I Obviously, that moderated anticipate year. the any the on with from we mix have really real as anticipate cost we a that do have future offset gross efficiencies will And will much can the this product that But well Matt. to We achieve improvements big margin. didn't what for with expansion. to come which talk bit. product in bottom see. sales the Sure. launches, in benefit we as that for Thanks start pressures can that

which area, you impact be going organization to of the But biggest took when the forward. about will time expense and in programs projects the the takes we provide a puts to in about lot benefit very or think then thinking deliberate and operating

investments. prioritize work taking facilities we of We're And and so how as this as programs such the a we environment lines. those measures number hybrid R&D along we consolidation in rethink of other

burden. will look activities and model. a improve of launch to of optimize customer Tandem of base ways then A those today that we that we're abilities comes to our business digitize and And greatly some that how to the the require source continuing from our customer-facing we with headcount automate support have for lot that heavy

when the still line, you EBITDA about think on together factors ended expand onset and with where confident adjusted to about new margins but felt in longer So acquisitions pressure all put the margin term. we this the at a a does XXXX bottom those year we very of X% you put those the little

from next line question comes of Lake Thank with Markets. you. Brooks Capital Street And our the O'Neil

us your Thank economy maybe what and you and as just to as you could impacts different whether give beginning as anything for the think on you softening my competitive the side question. are curious, you're a impact parse Thanks of factors the do what you lot. John, of you and you're competition the than and I'm seeing the equation? just expected of about think for taking well sense QX, perhaps Leigh, macro QX in out see the

the way worse. fairly to back going And say we've would in anticipate better. I that, the mean no I consistent. no it's been this would things this Yeah. throughout said, that quarter been being Brooks. seen year I that to that that entire November, in look we by if mean third year. it's you is And It's be the think Hi, call remain I

in and are to there's change, Control-IQ we because worse. not no the year to the get that say us said much growth activities it's going the of think focus we're would no really And the for product the past. so in the But these rate they and growth increase better, to prepared in used of is I new to benefits really got back we've our that and awareness execution change I really planned on intent curve remarks, drive as been company of really the a that

competition, John? In

mean, I competition same thing say Yeah. with the I would as well.

Okay.

the And with question line Research. Chris Thank from our you. comes of next Pasqual Nephron

Thanks the for taking questions.

want dig the on in to Just guidance. U.S.

the seems is digits this in we it run new being opportunity, starts probably like year. the math As baking low-double renewal guidance patient on down

I'd math curious if right just that's So different or you gets your be place. a first, to

I think that's the in ballpark, Chris.

One we've especially much of the we one tremendous see fourth much year, drivers to we quarter this can that growth that expect go just last really the pumpers, as what And into is biggest It's That count seen healthier the level the we opportunity. on which the half the that we is with the some adding renewal pumpers year. environment. a year, on some in this pressure in continue be will so still to seeing it we organization. part we new comp to to environment were will first we also of had although, of was new being

Right.

for little from you You've are benefit OUS four assuming years a been any market the renewals? And over Okay. on international now.

it start like through. might So to flow that seems

phenomenon lag XXXX a placed more to when It's where those noticeable is they benefit. and You're on and But half into that right. there year in from really back our moving and pumps when in pumps we'll you a begin keeping in longer to shipped first us the at of ship was that XXXX patients. full see We're for of that year. is get XXXX beginning of XX,XXX mind we just operations,

Thanks.

Steve with our the comes Oppenheimer. of from question line And Litchman you. next Thank

touch Thank you. more Wondering Hi, you just guys. on a little internal. if bit could

the the implied including you is digits, guess, about headwind that I transition. even think I terms talked guidance of low-double in

outside little on talk sort So on any for U.S.? you focused underlying in we things Control-IQ here regions be terms the of dynamics of are new how trending in the a And guys XXXX? about should can bit of you

operating. saying is which you of I in with still about still us for U.S. countries outside XX approximate opportunity X customers diabetes the with that in can million type X think the living we're the could Sure. start

the And great be So that would we've seen there. really opportunity. growth

we've the although on top some fact, placements line shipping in because to hard seen In growth of see dynamics, payments XXXX. of patient XX% in the

penetration. place I a to it's on great think push to So for continue us

So as we're the market expanding competitive there. conversion as well attracting

are I'd have an OUS that believe, also today, I that symposium Friday on is a as week ATD is a important presented. the that number Steve, say, starting of and will we've and this got which papers

the One be And country, the is people year. results for with study, to of to big of this us is going technology that creative NICE UK Control-IQ use a in UK. looking which and help the which to AID it's is at diabetes opportunity in means

jump I’ll Leigh. and John back Thanks, queue. in

care. Thank

Steve. Thanks,

question And line Hallum. Nowak you. Thank next our the comes from of Alex with Craig

everyone. know on but guidance, I in content the just about the we CDM are you're eventual including this [indiscernible] thinking launches, the not then [indiscernible] specular how Mobi. curious, [indiscernible] and also [indiscernible]

to QX when back, GX control also and Just base what online roll in happened out? remind us come

a understanding we had you. hard time really Alex,

sales saw type with the And that and the we CGM partners, what the think what Basal-IQ sensors. our in catalyst Launch? past launch I if was to question you of of maybe could is the compare Control-IQ launch new

Yeah, certainly.

the is great really back Basal-IQ the interesting sensor addition sensor would AID Control-IQ, really that to experience important. first Basal-IQ people diabetes the and in reduced opportunity in and sticks first then were GX I overall but important the and is system with meaningful with I you that the both say a burden experience patient look if And with effective in had clearly, the of device had new Control-IQ obviously, the the an sensor. also to market with products. But an we impact finger at the impact. had algorithms think that the the improving are the that is, introducing same and time,

insertion. in strength the our I painless have -- on be for it's better product in the second factor, of sales, a would me, and launch you the and the excuse to from half definitely that got said call, it's share ergonomic And in think to think -- the to year, a end much product. a I clearly in favorable times sales second this and quarter. as the It's half, of second case got scaling us. the a look GX form and It's of anticipate the we we product. at DexCom growth warm-up going if that the going effect We more -- much faster of forward integration, going quarter to drive see the are all of the we're which second

update. Okay. the Thanks for

Thank next Matt from the And you. comes Jefferies. with our line of question Taylor

taking for Thanks afternoon. Good the Hi. questions.

get to the you're tax wanted pump I understand so the expecting I hoping year, pressure U.S. half I maybe think new the that and to launch, U.S. externals starts, second grow ask this renewals, in these and help new some you And product in conditions some you the and more maybe in year. you of assumptions was you if when 'XX you to the can the around can? I of new half the about second thinking do better the improve, competitive guess, extend lap know that

Sure. It's question. great a

this the introductions make our So for I'll I there. do a product just guidance not have expectations first those in is year reminder that guess point new

do with anticipate our a integration CGM segment, we we're is we'll more we're pumpers inflections it's than what just today, expect seeing expand whether so new just new in from even can with more And to. those the we the Mobi the part market and continue that slightly own launches, comparing different with that But pressured just and that or baseline with still product product. reaching of attract that that, business shots the with we to people

leave there. I’ll right. Leigh. All it Thanks, Okay.

Sandler. Thank And of the Piper question line comes from Matthew O'Brien our you. next with

or the EBITDA outlook adjusted maybe misheard negative I'm would in assume I half, and I for positive in year in you that if company back, and where then and massive Thanks I back we're been is half year but for Leigh, the as point Leigh. to for the to John, so, downward And Hey, shape. the I I But there's guess, guidance. question. of over a the now this that first ramp taking a your good kind -- revenue Thanks last right. the year trajectory the the look in at taking think of hearing the said question. think

I outlook in got the to just EBITDA come we how year you've of line cut another through. situation you And these don't do as want as be to there? some the mean, put where on get expenses that I

fall can really gets else going So adjusted to out up full that year you call or there number? to off Thanks. are something that that there are you just to programs EBITDA

Sure. function levels levels. themselves A spending and moderated sales great deal really year, tied it’s across much the of expect not as to it stay is that of a we to the the so

typical the in So how shipments where lower about beginning the if seasonal the are have we think U.S., year. you of start curve sales at pump scaling, the

off coming quarter. XX% our of fact, first pump that would QX In could they the in shipments come down -- history could suggest

on the levels. have that puts really into with when sales OUS that beginning the and headwind dynamics current to quarter, it number, about you half first adjusted spending challenging for first that And that at heavily so the we're loaded pressure a EBITDA expecting the on which think of And the really then year. you in makes most see

of customer benefit to as organization drive side. the productivities -- be down is new And help for that So installed programs cost it scaling I as will across sales continues from start end are the to spending initiatives year we expect spending in to see see year the going the on to about about through that it as would a the expand. it much do the the -- up implementing that base levels. care lot is of today the support our ramp to But

Thank Okay. you.

And Wuensch question next Joanne line you. Thank the with from our of comes Citi.

for high-teens new were my into it looks question. just I in pumpers the a couple Is model, to right that pieces things. want like you the I If the taking quarter. put check down of the all math? Thank

that's me Let say in the ballpark.

in talking new Joanne, as year from see well in terms pumpers It about as like have looking to did year-over-year, pumpers highlight, going increase though, You're I the renewal we the a QX QX. most of new QX, would when modest customers. pressure you're did of that to

just to first follow-up, or essentially thoughtful growth more to to we're to just get get Okay. less X% I'm revenue as going And a how then in on ramp a quarter from little the figure easy including that or maybe products trialing ramp? you out guide. you're you you. comps full assuming helping that your in are new year since is else even Thank Other something there, not than

Yeah.

it's a the across U.S. challenge is last from half. curve. quarter follow The call quarter would OUS a the much year-over-year, back that when we the seasonal of separate really even and second markets. ramp had the what we're comparing healthier about in the the compared first environment -- typical ramp year important to the But the to So would separating year I

is comps belief So baseline expectations. the much the -- conversation in something and have beyond that's about you the part not so just about XXXX of year-over-year in

to the half, That's on top about come So particularly renewals million pumpers drive And continuing growth to a first you OUS then think have in really rate. new quarter. with you the headwind in in again, as this if markets, line $XX first to a continuing think about pressure year, Tandem. that the mostly growth

about so the comp anything else. And -- much and is those as elements it's year-over-year about it as

Okay. Thank you.

next with Thank of of comes question our line the Travis you. from And America. Steed Bank

Hey. question. the change on than heard like revenue. to on better sure for the a understood end per for low about I want supply reason But things the taking looks little then down year-over-year. the patient the worse. just I down clarification, guidance Thank guidance went quick And X% curious U.S. a I make was the change, no comments your did bit. you revenue it

math supply on understand to you. U.S. the want just revenue. So Thank the

Sure.

whole so And year that of that it business, -- that we're dollar range regard. growth million would I with $XX start giving from that typical question. the with. guidance and starting we're consensus a rate, with where range to with the as starting now in the So the obviously is a in characterize is important on Travis that usually number midpoint line rather is than point that with guidance right that top sitting P&L today comfortable giving we the just bottom very

data of usage supplies out terms of our in then nothing on basis, per per supplies. in person anything a the at patient a norm when of And looking suggests or that unusual there the was

so, basis, we center that of from you're see I began outside would really it look our in if did expectations. because a And you at don't the perspective. headwinds line speak a I looking independently, at U.S. on guess, U.S. on [indiscernible] worldwide supplies some just when But know was supplies transition clarify, the the I to the quarter. really the it with to distribution can very in much

Okay. you. Great. Thank

our Biegelsen Larry Wells next of line And comes from Fargo. with the you. question Thank

on Larry. Treybeck Nathan is This Hi. for

in question wait the expecting Mobi a renewals you for launch. or new terms because launch? in Just Are of any delay will starts the patients

far it's So I that's launch. something But and that not does to time itself a launch typically would advance. occur in that the much new say closer of in advance really

begin doesn't usually it clearance fact, a get In point. to you until

and then possible, between you commercial the of of continue sometimes to when your see the as evaluate we cost. (ph) program mitigate that. process help some level much and when a to today So start have But -- we're effectiveness launches you continuing to we'll as

perspective. says a Mobi anything we're At that coming not field this can say hearing there's much a from knowledge that customer of perspective point, I from even

not And so seeing to related any today, profit it. we're

questions the timing? so we've FDA base a few devices launch most a years. of you a in with diabetes And at delayed case guess, as reasonable And Mobi? what's follow-up, rounds expect Do recent for seen Thanks. just I

that questions I it's with timing And process is say difficult we're having stage would and normal in in think think process. underpin. the I of And clearance I the to I communications the dealing is you're of we the way that mean, right, just we're are what the we're that's looking predict. now. we mean, -- a right that be we of it. is Yeah. And we're mean, I after planning the responding half the the launch expect can't the quarter that for way to interaction that I to start to and scaled planning it, prepared that's year. we're we on a roughly, can but second would at that control clearance. the And

Thanks.

question of And next Baird. from our you. Johnson the Jeff Thank with comes RW line

guess, And Illinois wish is the to us to you. I'm with evening. just sure John. Hey, all off, you? his Thank Kim. can How are you along, just dear I near my first, continue for First letting well, heart in us, Good of hometown. personnel pass and my Pure, generosity

if you message, I John. appreciate that could So it. would pass

Absolutely.

then just here. And two Yeah. questions follow-up

headwinds this the don't build normalized asked. do to uncertainties. bigger in pattern XQ, We that environment to least some been at macro sequential normalized competitive Just we sequential that cushion competitive like a One, XX% happen comfortable a have declines some things something obviously, or Are is on have XQ can have that this uncertainty year? for there? you in and

We not XX% basis. Joanne's about confirm, just just you. to in decline my then upper make I I use math would I asked Thank on have think, closer she sure that's And number. you down, new just off on basis, is starts. to patient that U.S. question, a to want to on teens a global right? want

Sure.

feel So we've what that than consistency, John's that decline call, no comfortable the better, back seen, true we've quarter. And sequential earnings commentary of that worse we've part history environment the is is starting question, would to last the since the say going that I seen with first that, no maintain in I to seen. hold

about that from make trends at we're seasonality so those it of same thinking comfortable the historical point. lines And sense this along would

declines, market. the And very the at when been then patients, I've we've in focused terms that conversation talking having least on to been of patient new been I've U.S.

And with much seeing what that been have with have we they've up and in so people we're line would come suggesting what that's pretty agree models, within been the and commenting their what, anticipating. to I that percentages are

the U.S. get for to high-teens U.S. comment? you're that high-teens down XQ? can the talk U.S., just So in for you're closer a was you math we Because down sorry, offline, I saying to starts just want and down XX%, but again, clarify, new I about

ballpark, question and with would someone ahead, say year the as indication. we as it's and talking Jeff. agree we're then the look asked well about I in And had next I their XQ about

Fair enough. Thank you.

you. Thank comes line with Matthew from the next Stifel. And our question Blackman of

regulatory If in the afternoon, AMF does conceptually, commercialization? investment I the it AMF accelerate spend greedy, Leigh, intense rate and likely or Good and Capillary specifically, being we a everybody. consistent 'XX ‘XX annual from about I specific move call think EBITDA though, XXXX. through more Thanks. can into work headwind fairly for and from get 'XX into question. should appreciate Thanks out for clinical taking on my

-- own patch Matt, in think say, we to program. pump accelerating in our is pre-AMF way own, our our about The Sure. would that be expected this spending had that is let's plans, on we it, even own

follow with by so own acquiring And suit going we down to what our it's internal program, AMF standing anticipated.

And expectations years meeting across five targets. so in our R&D the falls line operating and that margin our original with

Yeah.

that. Appreciate Thank Okay. you.

our the with question comes Joshua you. of from Cowen. line Jennings next And Thank

the right. question. evening. access and taking account tech to program how assume attracted sales what's for 'XX for fair expectations the maybe sales I Thanks for a to ask about between just GAAP first wanted All amount the guidance? difference Good in internal and have the the non-GAAP to

for Thanks question. the Josh. Sure,

I change Tandem the that just this program of does Choice What is so same bit received of amount offers is it people transaction sell information the future. amount would t:slim cash at doesn't time. the an of same I the opportunity it guess today. for more we program the And economics that on We a pump highlight when today, little a

aware a t:slim of as all actually it. be today, if one to So they're making of even people buying eligible no They today. participate don't is to an election, have are

when quarter highly providing probably tracking So soon and time be be in that we've you the you the sales recognize progress at will the is as all get in Mobi, if that sales off do elect on, the table which based participate to clearance that use easily for could revenue the apply varied program. the to we're will the future. and we people because And bets as But non-GAAP the reason what it future. to or GAAP intent pretty in predict fourth of reported deferrals there's no versus today,

reflecting I on And historically, because seen progress our the to it's compare so to business non-GAAP business. encourage same we way are of the strongly you have the and sales focus people from with that best the economics the

for wanted And then to and about ask any you pipeline, piece updates that just regulatory Thank for platform? three just the just next development I Great. that. Thanks. or on the progress on of

in be Mobi's the the mean developing we shortly -- right on after the said sure. I available -- that it's middle now. product would commercialized. market XX we're think I Well, definitely t:slim of the We're

So it's line. next in

As a that. of on result that, diligently working we're

there's people We to other the frame it's significant important for living -- It's say many important to business. haven't product. We portion specific time different be just than portfolio believe Mobi it's t:slim a given after and going to going and to very segments an our of occur is with out diabetes. appeals that there

will the technology And enhancements a so a along life, more of product it's will to going They processor, distant that battery charging. to have be technology the powerful have enhanced. future. better wireless the lot of lifetime extend just It with into come that,

Thanks. Great.

now this And concludes for Thank you. call. you disconnect. conference may and participating, Thank you today's